[1]宋京翔,何 杨,王杰文,等.瞬感扫描式葡萄糖监测在Ⅱ型糖尿病病人胃肠癌围手术期的应用研究[J].肠外与肠内营养杂志,2022,(02):93-98.[doi:10.16151/j.1007-810x.2022.02.007]
　SONG Jing-xiang,HE Yang,WANG Jie-wen,et al.Applied research on flash glucose monitoring in type 2 diabetes mellitus patients with gastrointestinal cancer during perioperative period[J].PARENTERAL & ENTERAL NUTRITION,2022,(02):93-98.[doi:10.16151/j.1007-810x.2022.02.007]
点击复制

瞬感扫描式葡萄糖监测在Ⅱ型糖尿病病人胃肠癌围手术期的应用研究
分享到：

《肠外与肠内营养》杂志[ISSN:1007-810X/CN:32-1477/R]

卷:
期数:
2022年02期
页码:
93-98
栏目:
论著
出版日期:
2022-03-10

文章信息/Info

Title:
Applied research on flash glucose monitoring in type 2 diabetes mellitus patients with gastrointestinal cancer during perioperative period
作者:
宋京翔; 何 杨; 王杰文; 侯志冰
解放军联勤保障部队第九〇〇医院普通外科，福建福州 350025
Author(s):
SONG Jing-xiang;  HE Yang;  WANG Jie-wen;  HOU Zhi-bing
Department of General surgery, The 900th Hospital of the PLA Joint Logistic Support Force, Fuzhou 350025,Fujian, China
关键词:
扫描式葡萄糖监测 ; Ⅱ型糖尿病 ; 胃肠癌 ; 围手术期
Keywords:
Flash glucose monitoring;  T2DM;  Gastrointestinal cancer;  Perioperative period
分类号:
R587.1
DOI:
10.16151/j.1007-810x.2022.02.007
文献标志码:
A
摘要:
目的：研究瞬感扫描式葡萄糖监测在Ⅱ型糖尿病病人胃肠癌围手术期治疗中的临床应用价值。 方法：选取2018年9月至2021年2月间就诊于解放军联勤保障部队第九〇〇医院普通外科接受胃肠癌手术并符合纳入标准的98例Ⅱ型糖尿病病人，按照随机数字表法分为观察组（n = 48）和对照组（n = 50），观察组采用瞬感扫描式葡萄糖监测，对照组采用毛细血管血糖监测，围手术期均严格执行血糖监测管理，其余治疗一致。比较分析两组治疗前后平均空腹血糖（FPG）、平均餐后2 h血糖（2h PG）、高或低血糖发生次数、胰岛素用量、并发症发生率、住院时间、术前血糖达标时间、治疗费用及治疗满意度。 结果：治疗前两组病人的基线资料比较差异无统计学意义（P >0.05）；观察组和对照组测血糖的准确性与静脉生化葡萄糖无明显差异（P均 > 0.05），准确性均良好；观察组术前平均FPG、术前平均2 h PG、术后平均FPG、术后平均2 h PG均优于对照组（P < 0.05）；观察组发生高、低高血糖次数、术前血糖达标时间均优于对照组（P < 0.05）；两组并发症发生率无明显统计学差异（P > 0.05）；观察组胰岛素用量及住院时间较对照组均减少（P < 0.05），两组治疗总费用无差异（P > 0.05）；观察组治疗满意度明显高于对照组（P <0.05）。 结论：扫描式葡萄糖监测应用于Ⅱ型糖尿病病人胃肠癌围手术期的血糖监测及降糖治疗，准确性良好，提高了围手术期的血糖达标率，具有很高的临床应用价值。
Abstract:
Objective: To study the clinical application value of flash glucose monitoring (FGM) in the perioperative treatment of gastrointestinal cancer in type 2 diabetic patients. Methods: A total of 98 patients with type 2 diabetes who underwent gastrointestinal cancer surgery in our hospital between September 2018 and February 2021 were selected and divided into observation group (n = 48) and control group (n = 50) according to the random number table method. The observation group used FGM, and the control group used capillary blood glucose monitoring. The blood glucose monitoring and management were strictly implemented during the perioperative period, and the rest of the treatment was the same. The two groups were compared and analyzed the average fasting blood glucose (FPG) before and after treatment, the average 2 hours postprandial blood glucose (2h PG), the number of high or low blood glucose, insulin dosage, complication rate, hospital stay, preoperative blood glucose standard time, treatment cost and treatment satisfaction. Results: The baseline data of the two groups of the patients before treatment were not statistically significant (P > 0.05). There were no significant difference in the accuracy of blood glucose measurement and the venous biochemical glucose between the two groups (P > 0.05), and the accuracy of blood glucose measurement was good. The average preoperative FPG, preoperative average 2h PG, postoperative average FPG, and postoperative average 2h PG of observation group were significantly better than the control group (P < 0.05). The occurrence of hypoglycemia, the number of hyperglycemia, and the preoperative blood glucose standard time of observation group were significantly better than the control group (P < 0.05). There was no significant difference in the incidence of complications between the two groups (P > 0.05). The insulin dosage and hospital stay in the observation group were both lower than those in the control group (P < 0.05). There was no difference in the total cost of treatment between the two groups (P > 0.05). The treatment satisfaction of the observation group was significantly higher than that of the control group (P < 0.05). Conclusion: The accuracy of FGM is good to the gastrointestinal cancer patients with type 2 diabetes for the perioperative blood glucose monitoring and hypoglycemic treatment, which is helpful to improve the perioperative blood glucose compliance rate. It has high clinical application value.

参考文献/References:


[1] 陈国芳，孙 敏，刘 超. 围手术期血糖监控的策略与意义. 国际内分泌代谢杂志,2008,28(6):393-395.
[2] Su G，Mi SH，Tao H，et al. Impact of admission glycemic variability，glucose，and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction. Diabetes Care,2013,36(4):1026-1032.
[3] 匡荣康，顾 熙. 南京某三级医院2015至2019年间胃肠道恶性肿瘤病人营养风险和营养治疗现状调查分析 . 肠外与肠内营养,2020,27(6):350-354.
[4] 杨 翔，陈 敏，万文辉，等 . 肠内营养混悬液（TPF-DM）对超高龄2 型糖尿病病人营养、糖脂代谢及免疫功能的影响. 肠外与肠内营养,2021,28(3):144-146.
[5] 高 卉, 黄宇光, 许 力，等 . 围术期血糖管理专家共识(2020版). 2021-07-15.
[6] 陈莉明，周 健，包玉倩，等. 中国扫描式葡萄糖监测技术临床应用专家共识（2018 年版）. 中华糖尿病杂志, 2018, 10(11):698-699.
[7] Bailey T，Bode BW，Christiansen MP，et al. The performance and usabilityof a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther,2015,17(11):787-794.
[8] Ji L，Guo X，Guo L，et al. A multicenter evaluation of the performance and usability of a novel glucose monitoring system in Chinese adults with diabetes. J Diabetes Sci Technol,2017,11(2):290-295.
[9] Haak T，Hanaire H，Ajjan R，et al. Use of flash glucose-sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes. Diabetes Ther,2017,8(3): 573-586.
[10] Chamberlain JJ, Doyle-Delgado K, Peterson L， et al. DiabetesTechnology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med,2019,171(6):415-420.
[11] 戴如春，李 鑫，张 玲 . 糖尿病患者围术期血糖管理策略探讨. 中国医刊,2013,48(9):10-14.
[12] 李春霖，徐 岩. 实时动态血糖监测系统的临床应用. 中华医学会、中华医学会内分泌学分会、中华医学会第十次全国内分泌学学术会议论文汇编,2011,70-71.
[13] Sadoskas D，Suder NC，Wukich DK. Perioperative Glycemic Control and the Effect on Surgical Site Infections in Diabetic Patients Undergoing Foot and Ankle Surgery. Foot and ankle specialist,2016,9(1):24-30.
[14] Buehler L，Fayrman M，Alexopoulos AS，et al. The impact of hyperglycemia and obesity on hospitalization costs and clinical outcome in general surgery patients. J Diabetes Complications,2015,29(8):1177-1182.
[15] American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care,2013,36(4):1033-1046.
[16] Ueno K, Chujo D, Takahashi N, et al. Patient Satisfaction and Clinical Efficacy of Flash Glucose Monitoring in Patients with Type 1 Diabetes: A Prospective, Single-Center, Single-Arm Study. Diabetes Ther,2020,11(8):1883-1890.

备注/Memo

备注/Memo:
作者简介 ：宋京翔，副主任医师，医学博士，主要从事胃肠道恶性肿瘤综合治疗及营养支持研究。E-mail：13950496785@163.com 通讯作者 ：侯志冰，E-mail：262010447@qq.com
更新日期/Last Update: 1900-01-01